(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | -315.33%-668.16K | -229.62%-1.62M | 108.51%117.01K | 93.82%-1.7M | 99.37%-140.9K | 125.47%310.29K | 79.62%-492.91K | 14.91%-1.37M | -360.46%-27.45M | -871.56%-22.2M |
Other non cashItems | -47.92%98.73K | 0.16%98.27K | 0.87%98.32K | -111.36%-2.21M | -113.16%-2.6M | 1,790.39%189.58K | 2,481.84%98.11K | 139.79%97.47K | 1,035.35%19.49M | 1,540.53%19.74M |
Change in working capital | 224.86%195.04K | 97.70%-8.88K | -169.67%-70.65K | -216.72%-194.1K | 26.00%246.93K | -511.02%-156.2K | -614.02%-386.23K | 171.00%101.41K | 186.34%166.3K | -37.67%195.97K |
-Change in receivables | --0 | --0 | --0 | 221.88%42K | 1,191.29%105K | 0.00%-21K | 1.40%-21K | -7,066.89%-21K | -198.67%-34.46K | -61.90%8.13K |
-Change in prepaid assets | 38.04%-30.33K | 179.14%20.86K | -36.24%22.54K | 901.19%16.22K | 1.32%22.35K | 24.44%-48.95K | -63.40%7.47K | 74.32%35.35K | 97.16%-2.03K | -83.88%22.06K |
-Change in other current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 59.40%-160.74K | 50.81%-360.68K | -76.07%-408.2K | 29.40%-1.84M | 35.56%-476.59K | 11.45%-395.94K | -61.16%-733.23K | 75.88%-231.84K | 19.19%-2.6M | 14.57%-739.63K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Net PPE purchase and sale | --0 | ---- | ---- | 99.87%-3.78K | --0 | --0 | ---- | ---- | -29.01%-2.92M | 110.07%81.62K |
Net investment purchase and sale | -20.11%235.25K | 43.75%399K | -88.31%87.41K | --1.48M | --156K | --294.46K | --277.56K | --747.73K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -20.11%235.25K | 45.74%399K | -88.31%87.41K | 150.42%1.47M | 69.03%156K | 8,401.78%294.46K | 7,799.04%273.78K | 124.88%747.73K | -97.95%-2.92M | 111.39%92.29K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | -53.18%-42.89K | -2.12%-42.89K | -2.12%-42.89K | -6.82%-169.14K | -7.50%-57.15K | 20.14%-28K | -19.79%-42K | -19.80%-42K | -168.53%-158.34K | -51.64%-53.16K |
Net other financing activities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -53.18%-42.89K | -2.12%-42.89K | -2.12%-42.89K | -6.82%-169.14K | -7.50%-57.15K | 20.14%-28K | -19.79%-42K | -19.80%-42K | -101.40%-158.34K | -100.93%-53.16K |
Net cash flow | ||||||||||
Beginning cash position | -92.68%69.12K | -94.90%73.68K | -55.01%437.35K | -85.39%972.12K | -51.27%815.09K | -56.24%944.56K | -45.47%1.45M | -85.39%972.12K | 36,010.44%6.65M | -35.32%1.67M |
Current changes in cash | 124.42%31.62K | 99.09%-4.57K | -176.74%-363.67K | 90.59%-534.77K | 46.08%-377.74K | 73.34%-129.47K | -1.60%-501.45K | 111.84%473.89K | -185.63%-5.68M | -117.22%-700.51K |
End cash position | -87.64%100.74K | -92.68%69.12K | -94.90%73.68K | -55.01%437.35K | -55.01%437.35K | -51.27%815.09K | -56.24%944.56K | -45.47%1.45M | -85.39%972.12K | -85.39%972.12K |
Free cash from | 59.40%-160.74K | 51.06%-360.68K | -76.07%-408.2K | 66.66%-1.84M | 27.57%-476.59K | 11.45%-395.94K | -62.00%-737.01K | 94.15%-231.84K | -0.70%-5.52M | 60.74%-658.02K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data